Protecting the Maternal Heart From Pregnancy-Associated Heart Disease
Protecting the Maternal Heart From Pregnancy-Associated Heart Disease
批准号:
10192771
负责人:
MICHELLE L MATTER
金额:
$38.5万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-13 至 2023-06-30
关键词:
AcuteAdenovirusesAdhesionsAdultAminoacyl-tRNA hydrolaseApoptosisAttenuatedAutomobile DrivingBCL2 geneBirthCASP3 geneCalciumCardiac MyocytesCell DeathCell SurvivalCellsCellular StressCellular biologyChronicDataDefense MechanismsDiseaseDoseEtiologyFamilyFemaleFunctional disorderGene MutationGenesGenetic TranscriptionHeartHeart AbnormalitiesHeart DiseasesHeart failureHumanHypertrophyIn VitroIntegrinsKnockout MiceLifeMCL1 geneMaternal MortalityMechanical StressMechanicsMediatingMitochondriaMolecularMolecular BiologyMorbidity - disease rateMusMutationMyosin ATPaseMyosin Heavy ChainsNormal CellOxidative StressPI3K/AKTPathogenesisPathogenicityPathway interactionsPatientsPerinatalPeriodicityPersonsPhenotypePlayPostpartum PeriodPre-Clinical ModelPregnancyPregnancy ComplicationsPregnant WomenProteinsRattusReportingRiskRoleSamplingSignal PathwaySignal TransductionStressStretchingTestingTherapeuticUnited StatesVascular Endothelial Growth FactorsWomanWorkcardioprotectionhuman old age (65+)infancyinhibitor/antagonistinsightknock-downmalematernal morbiditymortalitymouse modelmutantperipartum cardiomyopathypre-clinicalpregnantprotein expressionresponsetargeted treatmenttherapeutic target
中文摘要
项目总结
英文摘要
Project Summary
Postpartum cardiomyopathy (PPCM) is a disease of unknown etiology that arises as
a complication of pregnancy in women with no prior heart disease. It occurs in
1:1800 to 1:3500 births in the United States and is characterized by an acute onset
of heart failure during the last month of pregnancy or within five months postpartum.
PPCM is a major cause of maternal morbidity and mortality with no PPCM-specific
treatment options available. During pregnancy, pregnancy-associated hypertrophy
initiates the activation of cardiomyocyte protective signaling pathways that block
stress-mediated apoptosis. In PPCM patients there is an increase in cardiomyocyte
apoptosis that leads to irreversible dysfunction and heart failure. The cellular
mechanisms driving cardiomyocyte apoptosis are not fully understood. We have
identified a gene PTRH2 (also called Bit-1) that is evolutionarily conserved, mediates
integrin regulated cell survival and apoptosis, and mutations in this gene promote
multisystem disease in humans. We hypothesize that PTRH2 is essential for
cardioprotection from peripartum stresses in the maternal heart. To study this we
developed a cardiomyocyte-specific deletion of PTRH2 (CKO). CKO male and never-
pregnant female mice demonstrate no heart defects and live to old age. However,
100% of CKO pregnant female mice develop PPCM in a dose-dependent manner
(CKO>HET). We will use cell and molecular biology and our CKO mice to determine
how PTRH2 mediates cardioprotection, test whether PTRH2 associated proteins
abrogate the PPCM phenotype in CKO pregnant mice, determine whether PTRH2
expression blocks hypertrophy and examine PPCM patient heart samples for PTRH2
gene mutations. The proposed project has the potential to identify an essential
survival pathway that is activated in pregnancy-associated hypertrophy, test PTRH2
directed therapeutic strategies in a preclinical mouse model of PPCM and determine
whether mutations in PTRH2 promote PPCM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protecting the maternal heart from pregnancy associated heart disease
-
批准号:10767091
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2023
-
负责人:MICHELLE L MATTER
-
依托单位:
Protecting the Maternal Heart From Pregnancy-Associated Heart Disease
-
批准号:10438833
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2018
-
负责人:MICHELLE L MATTER
-
依托单位:
Protecting the Maternal Heart From Pregnancy-Associated Heart Disease
-
批准号:9762134
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2018
-
负责人:MICHELLE L MATTER
-
依托单位:
Regulation of endothelial permeability in sepsis
-
批准号:8525409
-
项目类别:
-
资助金额:$27.86万
-
财政年份:2012
-
负责人:MICHELLE L MATTER
-
依托单位:
Regulation of endothelial permeability in sepsis
-
批准号:8717691
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2012
-
负责人:MICHELLE L MATTER
-
依托单位:
Regulation of endothelial permeability in sepsis
-
批准号:8343175
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2012
-
负责人:MICHELLE L MATTER
-
依托单位:
INTEGRIN-MEDIATED CELL SURVIVAL IN CARDIOVASCULAR DISEASE
-
批准号:8360589
-
项目类别:
-
资助金额:$45.39万
-
财政年份:2011
-
负责人:MICHELLE L MATTER
-
依托单位:
INTEGRIN-MEDIATED CELL SURVIVAL IN CARDIOVASCULAR DISEASE
-
批准号:8167740
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2010
-
负责人:MICHELLE L MATTER
-
依托单位:
INTEGRIN-MEDIATED CELL SURVIVAL IN CARDIOVASCULAR DISEASE
-
批准号:7959639
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2009
-
负责人:MICHELLE L MATTER
-
依托单位:
INTEGRIN-MEDIATED CELL SURVIVAL IN CARDIOVASCULAR DISEASE
-
批准号:7720343
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2008
-
负责人:MICHELLE L MATTER
-
依托单位:
THE PROTEINS RESPONSIBLE FOR INTEGRIN-MEDIATED CELL SURVIVAL
-
批准号:7609912
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2007
-
负责人:MICHELLE L MATTER
-
依托单位:
THE PROTEINS RESPONSIBLE FOR INTEGRIN-MEDIATED CELL SURVIVAL
-
批准号:7170546
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2005
-
负责人:MICHELLE L MATTER
-
依托单位:
海外基金